Reckitt Benckiser Group Plc (LON:RB)‘s stock had its “hold” rating reiterated by stock analysts at Kepler Capital Markets in a research note issued to investors on Wednesday, October 18th. They currently have a GBX 7,300 ($96.01) target price on the stock. Kepler Capital Markets’ price target would indicate a potential upside of 11.52% from the company’s previous close.
RB has been the topic of a number of other research reports. J P Morgan Chase & Co boosted their price objective on Reckitt Benckiser Group Plc from GBX 7,250 ($95.36) to GBX 7,300 ($96.01) and gave the stock a “neutral” rating in a research note on Tuesday, June 20th. Goldman Sachs Group, Inc. (The) lowered their price objective on Reckitt Benckiser Group Plc from GBX 8,130 ($106.93) to GBX 7,920 ($104.17) and set a “neutral” rating on the stock in a research note on Thursday, September 21st. Societe Generale set a GBX 7,800 ($102.59) target price on Reckitt Benckiser Group Plc and gave the company a “neutral” rating in a research report on Tuesday, September 5th. Jefferies Group LLC reduced their target price on Reckitt Benckiser Group Plc from GBX 8,200 ($107.85) to GBX 8,150 ($107.19) and set a “hold” rating on the stock in a research report on Tuesday, July 25th. Finally, Credit Suisse Group restated an “outperform” rating and issued a GBX 7,700 ($101.28) target price on shares of Reckitt Benckiser Group Plc in a research report on Friday, October 13th. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and eight have assigned a buy rating to the stock. The company has a consensus rating of “Hold” and a consensus price target of GBX 7,757.73 ($102.04).
Shares of Reckitt Benckiser Group Plc (LON:RB) traded down GBX 37 ($0.49) during trading hours on Wednesday, hitting GBX 6,546 ($86.10). The stock had a trading volume of 1,667,602 shares, compared to its average volume of 1,500,000. Reckitt Benckiser Group Plc has a 12-month low of GBX 6,496 ($85.44) and a 12-month high of GBX 8,110.43 ($106.67).
In other Reckitt Benckiser Group Plc news, insider Christopher Sinclair acquired 2,800 shares of the stock in a transaction dated Wednesday, November 1st. The stock was acquired at an average cost of GBX 6,597 ($86.77) per share, with a total value of £184,716 ($242,951.47).
About Reckitt Benckiser Group Plc
Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).
Receive News & Ratings for Reckitt Benckiser Group Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group Plc and related companies with our FREE daily email newsletter.